Australia - English - Department of Health (Therapeutic Goods Administration)

biocelect pty ltd - salmonella typhi -

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - iron sucrose, quantity: 540 mg/ml (equivalent: iron, qty 20 mg/ml) - injection, concentrated - excipient ingredients: sodium hydroxide; water for injections - venofer is indicated for the treatment of iron deficiency anaemia in patients undergoing chronic haemodialysis and who are receiving supplemental erythropoietin therapy.,the diagnosis of iron deficiency must be based on appropriate laboratory tests (e.g. serum ferritin, serum iron, transferrin saturation and hypochromic red cells).

Australia - English - Department of Health (Therapeutic Goods Administration)

merck serono australia pty ltd - metacresol,somatropin,water for injections -

Australia - English - Department of Health (Therapeutic Goods Administration)

merck healthcare pty ltd - somatropin -

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - ferric carboxymaltose, quantity: 3.6 g (equivalent: iron, qty 1000 mg) - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - ferinject is indicated for the treatment of iron deficiency in adults and adolescents aged 14 years and older when:,? oral iron preparations are ineffective ? oral iron preparations cannot be used ? there is a clinical need to deliver iron rapidly,the diagnosis of iron deficiency must be based on laboratory tests.,ferinject is indicated for the treatment of iron deficiency anaemia in children aged 1 to 13 years when:,? oral iron preparations are ineffective ? oral iron preparations cannot be used,the diagnosis of iron deficiency anaemia must be based on laboratory tests.

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - patiromer sorbitex calcium, quantity: 33.6 g (equivalent: patiromer, qty 16.8 g) - powder, oral - excipient ingredients: xanthan gum - veltassa is indicated for the treatment of hyperkalaemia in adults.

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - patiromer sorbitex calcium, quantity: 50.4 g (equivalent: patiromer, qty 25.2 g) - powder, oral - excipient ingredients: xanthan gum - veltassa is indicated for the treatment of hyperkalaemia in adults.

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - patiromer sorbitex calcium, quantity: 16.8 g (equivalent: patiromer, qty 8.4 g) - powder, oral - excipient ingredients: xanthan gum - veltassa is indicated for the treatment of hyperkalaemia in adults.

Australia - English - Department of Health (Therapeutic Goods Administration)

biocelect pty ltd - salmonella typhi, quantity: 2000 million organisms - capsule, enteric - excipient ingredients: sucrose; ascorbic acid; protein hydrolysate; ethylene glycol; lactose; hypromellose phthalate; erythrosine; iron oxide red; titanium dioxide; magnesium stearate; diethyl phthalate; gelatin; iron oxide yellow - vivotif oral is indicated for active immunisation against typhoid in adults and children above 6 years of age. effectiveness in children below 6 years of age is not known at present.

Australia - English - Department of Health (Therapeutic Goods Administration)

william a cook australia pty ltd - 56709 - chorionic villus sampling needle set - intended to obtain samples of chorionic villi using a transabdominal approach under ultrasound guidance.